Life Science REIT PLC Notice of Full Year Results (0494R)

TIDMLABS

RNS Number : 0494R

Life Science REIT PLC

27 February 2023

LEI: 213800RG7JNX7K8F7525

Life Science REIT plc

("Life Science REIT" or the "Company")

Notice of Full Year Results

Life Science REIT (LSE: LABS), the real estate investment trust focused on UK life science properties, is pleased to announce that it will report its results for the year ended 31 December 2022 on Monday 27 March 2023.

A meeting for analysts will be held at 10.00am on the morning of 27 March at the offices of Buchanan, 107 Cheapside, London EC2V 6DN. The meeting will be hosted by Simon Farnsworth, Managing Director, and David Lewis, Director of Operations and Finance, from the Company's Investment Adviser, Ironstone Asset Management.

Analysts who wish to attend the meeting, please RSVP to lifesciencereit@buchanan.uk.com

A live audiocast of the meeting will be available via at the following link:

https://webcasting.buchanan.uk.com/broadcast/63eb7e5ac09ed3517c0b3233

Following the meeting, a recording of the audiocast will be made available for replay at the Company's website, https://lifesciencereit.co.uk

FOR FURTHER INFORMATION, PLEASE CONTACT:

Enquiries:

 
 Link Company Matters Limited - Company 
  Secretary 
 labs_cosec@linkgroup.co.uk 
 
 Ironstone Asset Management - Investment 
  Adviser 
 Simon Farnsworth                                via Buchanan below 
 
 Panmure Gordon (UK) Limited -Joint Corporate 
  Broker                                         +44 20 7886 2500 
 Alex Collins / Chloe Ponsonby / Tom Scrivens 
 
 Jefferies International Limited - Joint 
  Corporate Broker                               +44 20 7029 8000 
 Tom Yeadon / Andrew Morris / Oliver Nott 
  / Harry Randall 
 
 G10 Capital Limited - AIFM                      +44 20 7397 5450 
 Verity Morgan-Jones / Paul Cowland 
 
 
 Buchanan - Financial PR                         +44 20 7466 5000 
 Mark Court / Henry Wilson / Verity Parker 
 LifeSciencereit@buchanan.uk.com

Notes to editors

Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the "Golden Triangle" of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter and its strategic vision is to become the property provider of choice for life science companies in the UK.

Life Science REIT is addressing the acute demand-supply imbalance for laboratory space in the "Golden Triangle", which is characterised by low vacancy rates and prime rental increases. The UK life science sector itself is benefiting from a buoyant early-stage funding environment, driving demand for laboratory space.

The Company's diverse portfolio of assets ranges from a 20-acre science park currently under development through to fully let buildings, with an important part of the Company's strategy being the conversion of existing properties to laboratory space.

The Company's investment policy is focused on capital growth whilst also providing a growing level of income.

Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.

Further information is available at https://lifesciencereit.co.uk . To sign up for email alerts, please visit https://lifesciencereit.co.uk/investors/ .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORDZLFLXLLFBBZ

(END) Dow Jones Newswires

February 27, 2023 02:01 ET (07:01 GMT)

Life Science Reit (LSE:LABS)
Historical Stock Chart
From Oct 2024 to Nov 2024